Antiviral diseases

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Gefitinib and Celecoxib  inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytical ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 19/December/2017,  11.40 pm
Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Gefitinib and Celecoxib  inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytical ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 19/December/2017,  11.40 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Efavirenz and Ritonavir (ER) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 15/December/2017,  9.23 am
Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Efavirenz and Ritonavir (ER) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 15/December/2017,  9.23 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 1/December/2017, 5.22 pm
Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 1/December/2017, 5.22 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Antiviral therapy for HIV virus:  A pharmaceutical mixture encompassing  Cidofovir and Ribavirin (CR) increases Heme oxygenase 2 (HO-2) expression,…

read more

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Cidofovir & Ribvirin (CR) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 28/November/2017,  6.41 am
Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Cidofovir & Ribvirin (CR) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 28/November/2017,  6.41 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Antiviral therapy against Neuroinvasive West Nile virus: Cidofovir, an antiviral agent, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 28/November/2017, 6.10 am
Antiviral therapy against Neuroinvasive West Nile virus: Cidofovir, an antiviral agent, increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 28/November/2017, 6.10 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109,…

read more

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Chloroquine & Lycorine (CAL) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 20/November/2017,  11.17 pm
Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Chloroquine & Lycorine (CAL) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1,  respiratory syncytial ,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 20/November/2017,  11.17 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say:  A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more
Start Typing